Early gastric cancer treatment outcomes study
Part of Cancer, Digestive system clinical trials.
This study looks at people with early-stage stomach cancer to learn more about how different treatments work. It uses information from patients who were treated at a specific hospital, which may help doctors better understand the best ways to treat this condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 90 years old.
- You have been diagnosed with stomach cancer that is in its early stage, meaning it has not spread deeply into the stomach wall or to other parts of the body.
- Your cancer was confirmed by a biopsy done before any treatment.
- You have given broad consent for your medical information to be used in research.
- You received your primary treatment at Beijing Friendship Hospital, which could be endoscopic removal, laparoscopic surgery, open surgery, or a combination.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses genetic sequencing to learn more about early stomach cancer and precancerous stomach polyps. It may help improve how these conditions are understood and potentially guide future care, using genetic information from stored tissue samples.
This trial tests whether a minimally invasive camera-guided surgical procedure (laparoscopy) can better detect hidden cancer spread in patients with advanced stomach cancer. The goal is to help doctors plan the best treatment and improve outcomes.
This trial tests an early treatment plan after stomach cancer surgery. It is for people who completed chemotherapy before surgery without serious side effects and had a short hospital stay.
This study tests a new, less invasive way to treat early stomach cancer using two types of endoscopes (thin, flexible tubes with cameras) together. It may be an option for people whose cancer has just started to grow into the deeper layer of the stomach wall but has not spread elsewhere.
This study looks at stomach (or stomach–esophagus junction) cancer tissue, treatment details, and patient-reported experiences to better predict how you may respond to standard chemotherapy. It may help personalize future treatment by identifying markers that connect your tumor environment and your expected outcomes.
This trial collects and studies tumor and lymph node samples from people with gastric cancer who have had chemotherapy and surgery. The goal is to understand how cancer responds to treatment and to improve future care.
Hear when a new Early Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.